Stocks and Investing Stocks and Investing
Thu, July 16, 2020
Wed, July 15, 2020

David Lebovitz Maintained (ASND) at Buy with Decreased Target to $177 on, Jul 15th, 2020


Published on 2024-10-27 09:44:42 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $181 to $177 on, Jul 15th, 2020.

David has made no other calls on ASND in the last 4 months.



There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with David


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $173 on, Wednesday, May 20th, 2020
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $208 on, Wednesday, May 20th, 2020
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $154 on, Wednesday, May 20th, 2020
  • Adam Walsh of "Stifel" Maintained at Strong Buy with Increased Target to $171 on, Monday, April 20th, 2020
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $201 on, Monday, April 20th, 2020

Contributing Sources